3R8G
AKR1C3 complex with ibuprofen
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-03-14 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.979417 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 57.794, 64.533, 96.177 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 19.730 - 1.799 |
R-factor | 0.17623 |
Rwork | 0.174 |
R-free | 0.21348 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2fgb |
RMSD bond length | 0.024 |
RMSD bond angle | 1.881 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 19.730 | 1.900 |
High resolution limit [Å] | 1.799 | 1.799 |
Rmerge | 0.074 | 0.576 |
Number of reflections | 34038 | |
<I/σ(I)> | 17.3 | 3.3 |
Completeness [%] | 99.7 | 98.8 |
Redundancy | 7 | 7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 275 | 200 mM sodium acetate, 20% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 275K |